Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
November 18, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 14, 2016 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
November 14, 2016 8-K current report HTML PDF XLS Add to Briefcase
October 19, 2016 8-K current report HTML PDF XLS Add to Briefcase
September 30, 2016 4 celniker, abbie HTML PDF XLS Add to Briefcase
September 28, 2016 SC 13D general statement of beneficial ownership HTML PDF XLS Add to Briefcase
September 28, 2016 3 clairmark investments ltd. HTML PDF XLS Add to Briefcase
September 28, 2016 D small company offering and sale of securities without registration HTML PDF
Add to Briefcase
September 26, 2016 4 kania, edwin m jr HTML PDF XLS Add to Briefcase
September 23, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
FirstPrevious
2
... NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
2.25
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on March 28, 2017
Delayed at least 20 minutes.